Quantitative structure-activity relationships of antiarrhythmic drugs

Current Pharmaceutical Design

Volumn 4, Issue 6, 1998, Pages 455-468

  Gupta, Satya P ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; DRUG ACTIVITY; DRUG INDICATION; DRUG STRUCTURE; HEART ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ELECTROPHYSIOLOGY; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031730204     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (144)

1. Bowman, W.C ; Rand, M.J Textbook of Pharmacology, 2nd ed , Blackwell Scientific Publications: London, 1980; Chaps 22 and 23.
2. Thomas, R.E. In Burgers's Medicinal Chemistry, 4th ed., pt 3, Wolf, M E , Ed ; John Wiley and Sons: New York, 1981; p. 47
3. (a) Hoffman, B F ; Bigger, J T , Jr. In The Pharmaceutical Basis of Therapeutics, 7th ed., Gilman, A G., Goodman, L.S.; Rall, T.W , Murad, F , Eds , Macmillan Publishing Company: New York, 1985; p. 716
4. (b) Bigger, J.T , Jr.; Hoffman, B.F. ibid , p. 748;
5. (c) Rudd, P , Blaschke, T.F. ibid., p. 784;
6. (d) Needleman, P., Corr, P.B ; Johnson, E M., Jr. ibid., p. 806;
7. (e) Brown, M.S.; Goldstein, J L ibid., p. 827.
8. Wit, A L , Hoffman, B.F.; Cranefield, P.F. Circ Res., 1972, 30, 1, 11.
9. Bigger, J.T., Jr. In Cardiovascular Arrhythmias ; Dreifus, L.S.; Likoff, W., Eds ; Grune and Stratton, Inc : NewYork, 1973, p. 13.
10. Wit, A L.; Rosen, M.R.; Hoffman, B F. Am. Heart J., 1975, 90, 265, 397
11. Cranefield, P.E. Circ. Res , 1977, 41, 415.
12. Szekeres, L.; Papp, G.J. Experimental Cardiac Arrhythmias and Antiarrhythmic Drugs, Akademiat Kiado, Budapest: Hungary, 1971.
13. Szekeres, L.; Papp, G J. Prog. Drug Res., 1962, 12, 292.
14. Batsford, W P.; Weisfolge, G.M.; Lau, S.H ; Damato, A.N. Am Heart J., 1974, 88, 733.
15. Morgan, P.H , Mathison, I.W. J Pharm. Sci., 1976, 65, 467.
16. Morgan, P.H.; Mathison, I.W. J. Pharm. Sci., 1976, 65, 635.
17. Vaughan Williams, E M. Adv. Drug. Res , 1974, 9, 69.
18. Hellenbrecht, D Naunyn-Schmiedeberg's Arch. Pharmacol., 1971, 271, 125
19. Lemmer, B.; Wiethold, G.; Hellenbrecht, D.; Bak, I.J.; Grobecker, H. Naunyn- Schmiedeberg's Arch. Pharmacol., 1972, 275, 299.
20. Wiethold, G.; Lemmer, D ; Hellenbrecht, D.; Grobecker, H.; Palm, D Naunyn- Schmiedeberg;s Arch. Pharmacol (Suppl), 1972, 274, R125
21. Wiethold, G.; Hellenbrecht, D.; Lemmer, B., Palm, D. Biochem Pharmacol , 1973, 22, 1437.
22. Barrett, A.M.; Cullum, V.A. Brit. J Pharmacol , 1968, 34, 43.
23. Madan, B.R.; Mishra, S.N.; Khanna, V K. Arch. Int Pharmacol Ther., 1969, 182, 121.
24. Howe, R.; Shanks, R G. Nature, 1966, 210, 1336.
25. Ferrini, R., Miragoli, G ; Croce, G Arzneim.-Forsch., 1968, 183, 829.
26. Musso, E.; Taccardi, B. Arch Int Pharmacol. Ther., 1970, 183, 173.
27. Hermansen, K. Brit. J. Pharmacol., 1969, 35, 476.
28. Davis, W.G. J Pharm Pharmacol., 1970, 22, 284.
29. Kubiniyi, H. QSAR : Hansch Analysis and Related Approaches, VCH Publishers: Weinheim-New York, 1993
30. Gupta, S.P.; Singh, P ; Bindal, M.C. Chem. Rev., 1983, 83, 633.
31. Gupta, S P., Chem. Rev., 1987, 87, 1183.
32. Gupta, S.P., Chem Rev., 1989, 89, 1765.
33. Gupta, S.P., Chem Rev., 1991, 91, 1109
34. Gupta, S.P., Chem. Rev., 1994, 94, 1994
35. Gupta, S.P., Prog Drug Res., 1995, 45, 67.
36. Gupta, S.P.; Gao, H.; Garg, R.; Babu, M.S.; Hansch, C. Chem. Rev , to be published.
37. Levy, J V Eur. J. Pharmacol., 1968, 2, 250.
38. Ariens, E J. Arch Pharmacol. Exp. Pathol., 1967, 257, 118
39. Hallenbrecht, D., Lemmer, B.; Wiethold, G.; Grobecker, H. Naunyn- Schmiedeberg's Arch. Pharmacol., 1973, 277, 211.
40. Jaagsma, J ; Nauta, W T J. Med. Chem , 1974, 17, 507
41. Jaagsma, J ; Nauta, W.T. J. Med. Chem , 1974, 20, 527.
42. Hellenbrecht, D.; Muller, K.F ; Grobecker, H. Eur. J. Pharmacol., 1974, 29, 223.
43. Lin, T.K J. Med. Chem., 1974, 17, 749.
44. Lin, T.K.; Chien, Y W.; Dean, R.R ; Dutt, J.E.; Sause, H W., Yen, C.H , Yonari, P.K. J Med. Chem., 1974, 17, 751.
45. Lin, T.K.; Chien, Y.W., Desai, H.B.; Yonan, P.K. Chem. Pharm. Bull., 1976, 24, 2739.
46. Tenthorey, P.A.; Block, A.J.; Ronfeld, R.A., McMaster, P.D.; Byrnes, E.W. J Med. Chem , 1981, 24, 798.
47. Rauls, D.O.; Baker, J.K. J. Med. Chem., 1979, 22, 81.
48. Mathison, I.W.; Baker, J.K. J Med. Chem., 1979, 18, 1227
49. Mathison, I.W.; Morgan, P.H.; Wojciechowski, N J.; Bandura, J.P.; Wennemark, J.R. J. Med. Chem., 1976, 19, 385.
50. Mathison, I.W.; Gueldner, R C. J. Org. Chem., 1968, 33, 2510
51. Mathison, I.W.; Gueldner, R.C ; Lawson, J W.; Fowler, S.J ; Peters, E.R. J. Med. Chem , 1968, 11, 997
52. Mathison, I.W.; Morgan, P.H.; Tidwell, R R.; Handrof, C.R. J. Pharm. Sci., 1972, 61, 637.
53. Mathison, I.W.; Morgan, P.H. J. Org. Chem., 1974, 39, 3210.
54. Mathison, I.W.; Morgan, P.H. J Med. Chem., 1974, 17, 1136
55. Seeman, P. Pharmacol. Rev., 1972, 24, 583.
56. Roth, S.H. Annu Rev. Pharmacol. Toxicol., 1979, 19, 159
57. Nuhn, P.; Frenzel, J.J ; Arnold, K. Pharmazie, 1979, 34, 131
58. Hansch, C.; Glave, W.R. Mol. Pharmacol., 1971, 7, 337
59. See, for example (a) Buchi, J.; Perlia, X. In Local Anesthetics; Lechat, P., Ed.; Pergamon Press: Oxford, 1971; Vol 1, sec. 8, p. 39 ; (b) Buchi, J.; Perlia, X. In Drug Design, Ariens, E.J., Ed., Academic press: New York, 1972; Vol. 3, p. 243; (c) Takman, B H ;Adams, H.J. In Burgers's Medicinal Chemistry, 4th ed ; pt. 3, Wolf, M.E , Ed.; John Wiley and Sons: New York, 1981; p. 645. (d) Ritchie, J.M ; Greene, N.M. In The Pharmacological Basis of Therepeutics, 7th ed., Gilman, A.G.; Goodman, L.S.; Rall, T.W ; Murad, F , Eds.; Macmillan Publishing Company New York, 1985; p. 302 ; (e) Calvey, T.N.; Williams, N. Principles of , Pharmacology for Anesthetics, Blackwell Scientific Publications: Oxford, 1982.
60. See, for example (a) Buchi, J.; Perlia, X. In Local Anesthetics; Lechat, P., Ed.; Pergamon Press: Oxford, 1971; Vol 1, sec. 8, p. 39 ; (b) Buchi, J.; Perlia, X. In Drug Design, Ariens, E.J., Ed., Academic press: New York, 1972; Vol. 3, p. 243; (c) Takman, B H ;Adams, H.J. In Burgers's Medicinal Chemistry, 4th ed ; pt. 3, Wolf, M.E , Ed.; John Wiley and Sons: New York, 1981; p. 645. (d) Ritchie, J.M ; Greene, N.M. In The Pharmacological Basis of Therepeutics, 7th ed., Gilman, A.G.; Goodman, L.S.; Rall, T.W ; Murad, F , Eds.; Macmillan Publishing Company New York, 1985; p. 302 ; (e) Calvey, T.N.; Williams, N. Principles of , Pharmacology for Anesthetics, Blackwell Scientific Publications: Oxford, 1982.
61. See, for example (a) Buchi, J.; Perlia, X. In Local Anesthetics; Lechat, P., Ed.; Pergamon Press: Oxford, 1971; Vol 1, sec. 8, p. 39 ; (b) Buchi, J.; Perlia, X. In Drug Design, Ariens, E.J., Ed., Academic press: New York, 1972; Vol. 3, p. 243; (c) Takman, B H ;Adams, H.J. In Burgers's Medicinal Chemistry, 4th ed ; pt. 3, Wolf, M.E , Ed.; John Wiley and Sons: New York, 1981; p. 645. (d) Ritchie, J.M ; Greene, N.M. In The Pharmacological Basis of Therepeutics, 7th ed., Gilman, A.G.; Goodman, L.S.; Rall, T.W ; Murad, F , Eds.; Macmillan Publishing Company New York, 1985; p. 302 ; (e) Calvey, T.N.; Williams, N. Principles of , Pharmacology for Anesthetics, Blackwell Scientific Publications: Oxford, 1982.
62. See, for example (a) Buchi, J.; Perlia, X. In Local Anesthetics; Lechat, P., Ed.; Pergamon Press: Oxford, 1971; Vol 1, sec. 8, p. 39 ; (b) Buchi, J.; Perlia, X. In Drug Design, Ariens, E.J., Ed., Academic press: New York, 1972; Vol. 3, p. 243; (c) Takman, B H ;Adams, H.J. In Burgers's Medicinal Chemistry, 4th ed ; pt. 3, Wolf, M.E , Ed.; John Wiley and Sons: New York, 1981; p. 645. (d) Ritchie, J.M ; Greene, N.M. In The Pharmacological Basis of Therepeutics, 7th ed., Gilman, A.G.; Goodman, L.S.; Rall, T.W ; Murad, F , Eds.; Macmillan Publishing Company New York, 1985; p. 302 ; (e) Calvey, T.N.; Williams, N. Principles of , Pharmacology for Anesthetics, Blackwell Scientific Publications: Oxford, 1982.
63. See, for example (a) Buchi, J.; Perlia, X. In Local Anesthetics; Lechat, P., Ed.; Pergamon Press: Oxford, 1971; Vol 1, sec. 8, p. 39 ; (b) Buchi, J.; Perlia, X. In Drug Design, Ariens, E.J., Ed., Academic press: New York, 1972; Vol. 3, p. 243; (c) Takman, B H ;Adams, H.J. In Burgers's Medicinal Chemistry, 4th ed ; pt. 3, Wolf, M.E , Ed.; John Wiley and Sons: New York, 1981; p. 645. (d) Ritchie, J.M ; Greene, N.M. In The Pharmacological Basis of Therepeutics, 7th ed., Gilman, A.G.; Goodman, L.S.; Rall, T.W ; Murad, F , Eds.; Macmillan Publishing Company New York, 1985; p. 302 ; (e) Calvey, T.N.; Williams, N. Principles of , Pharmacology for Anesthetics, Blackwell Scientific Publications: Oxford, 1982.
64. Hansch, C., Fujita, T. J. Am. Chem Soc., 1964, 86, 1616
65. Hansch, C.; Fujita, T. J. Med. Chem., 1970, 13, 957.
66. Dunning, B , Jr , Dunning, F.; Reid, E.E. J Am. Chem. Soc , 1936, 58, 1565
67. Bartels, E., Nachmansohn. D Biochem. Z., 1965, 342, 359.
68. Galinsky, A.M ; Gearien, J.E.; Perkins, A J ; Susina, S V J. Med Chem., 1963, 6, 320.
69. Agin, D ; Hersh, L ; Holtzman, D. Proc. Natl. Acad. Sci. U.S.A., 1965, 53, 952
70. Kier, L.B Molecular Orbital Theory in Drug Research, Academic Press: New York, 1971
71. Handa, A.; Bindal, M C.; Prabhakar, Y.S ; Gupta, S.P. Indian J. Biochem. Biophys., 1983, 20, 318 See also: Gupta, S.P.; Prabhakar, Y.S J. Sci. Ind. Res., 1985, 44, 189.
72. Handa, A.; Bindal, M C.; Prabhakar, Y.S ; Gupta, S.P. Indian J. Biochem. Biophys., 1983, 20, 318 See also: Gupta, S.P.; Prabhakar, Y.S J. Sci. Ind. Res., 1985, 44, 189.
73. Hersh, L. Mol. Pharmacol., 1967, 3, 581.
74. Blaustein, M.P.; Goldman, D.E Science, 1966, 153, 429.
75. Feinstein, M B. J. Gen Physiol., 1964, 48, 357.
76. Jain, M K ; Wu, N Y.M ; Wray, L.V. Nature, 1975, 225, 494.
77. Otero, E P.; and Otero, E.A. Anal. Quim., 1975, 71, 907.
78. Butter, K.W ; Schneider, H.; Smith, I.C.P. Arch. Biochem. Biophys., 1973, 154, 548.
79. Feinstein, M.E.; Fernandez, S.M.; Sha'afi, R.I. Biochim. Biophys. Acta 1975, 413, 354
80. Rosenberg, P.H Naunyn-Schmiedeberg's Arch. Pharmacol., 1979, 307, 199
81. Ondrias, K ; Balgavy, S.; Stole, S.; Horvath, L.I. Biochim. Biophys. Acta, 1983, 732, 627.
82. Zipf, H.F. Pharm. Acta Helv., 1967, 42, 480.
83. Pesak, M ; Kopecky, F., Borovansky, A. In QSAR in Design of Bioactive Compounds, Kuchar, M., Ed.; J.R Prous Science Publishers: Spain, 1984, p. 209.
84. Ehrhardt, J.D.; Rouot, B.; Schwartz, J. Eur. J. Med. Chem., 1978, 13, 235.
85. Courriere, P.; Paubel, J.P ; Niviere, P.; Foussard-Blanpin, O. Eur. J. Med. Chem., 1978, 13, 121.
86. Gupta, S.P.; Saha, R.N.; Gupta, J.K Res. Commun. Chem. Pathol. Pharmacol., 1990, 67, 297.
87. Nelson, P.H.; Srosberg, A.M ; Untch, K.G. J Med. Chem., 1980, 23, 180.
88. Kelusky, E.C.; Smith, I C.P. Mol Pharmacol., 1984, 26, 314.
89. Eftink, M.R ; Puri, R.K.; Ghahramani, M D. Biochim. Biophys. Acta, 1985, 813, 137.
90. Weber, M.; Changeux, J.P. Mol. Pharmacol., 1974, 10, 35
91. Trudell, J R. Anesthesiology, 1977, 46, 5
92. Seeman, P. Pharmacol. Rev., 1972, 24, 583.
93. Lee, A.G. Nature, 1976, 262, 545.
94. Hille. B In Progress in Anesthesiology; Fink, B.R.,Ed ; Raven Press: New York, 1980, Vol 2, p. 1
95. Postma, S.W ; Catterall, W.A. Mol. Pharmacol., 1984, 25, 219.
96. Henn, F.A.; Sperelakis, N. Biochim. Biophys. Acta, 1968, 163, 415
97. Anderson, N B. J. Pharmacol. Exp. Ther., 1968, 163, 393.
98. Roufogalis, B.D. Biochim Biophys. Acta 1973, 318, 360.
99. Garcia-Martin, E., Guitierrez-Merino, C. J Neurochem., 1986, 47, 668
100. Voeikov, V.V ; Lefkowitz, R J. Biochim Biophys Acta, 1980, 629, 266
101. Gordon, L M ; Dipple, I.D.; Sauerheber, R.D , Esgate, J.A ; Houslay, M D. J Supramol Struct 1980, 14, 21.
102. Richelson, E.; Prendergast, F.G ; Divenets-Romero, S.D. Biochem Pharmacol. 1978, 27, 2039.
103. Volpi, M , Sha'afi, R I.; Epstein, P.M.; Andrenyak, D M., Feinstein, M.B. Proc. Natl Acad. Sci. U.S.A., 1981, 78, 795
104. Tanaka, T.; Hidaka, H. Biochem. Biophys. Res Commun., 1981, 101, 447.
105. Waite, M , Sisson, P Biochemistry, 1972, 11, 3098
106. Aksentsev, S.D.; Konev, S V ; Rakovich, A A.; Okun, I M.; Kulikov, A.V. Gen. Physiol Biophys , 1982, 1, 403.
107. Frelin, C.; Vigne, P.; Lazdunski, M. Biochem Biophys. Res. Commun., 1982, 106, 967.
108. Mathews, J.C.; Collins, A. Biochem. Pharmacol., 1983, 32, 455.
109. Fishman, M.C., Spector, I. Proc Natl Acad Sci. U.S A , 1981, 78, 5245.
110. Bolger, G.T ; Marcus, K A; Daly, J.W.; Skolnick, P. J Pharmacol Exp. Ther., 1987, 240, 922.
111. Coyle, D.; Sperelakis, N. J. Pharmacol. Exp. Ther , 1987, 242, 1001.
112. Catterall, W.A. Trends Pharmacol. Sci., 1987, 8, 57.
113. Nishizawa, Y.; Gusovsky, F.; Daly, J.W. Mol. Pharmacol., 1988, 34, 707.
114. Gusovsky, F.; Daly, J.W. FEBS Lett., 1986, 199, 107.
115. Gusovsky, F.; Hollingsworth, E.B.; Daly, J.W. Proc. Natl. Acad Sci. U.S.A., 1986, 83, 3003
116. Gupta, S.P.; Gupta, J.K.; Saha, R.N. Drug Des. Deliv., 1990, 6, 131.
117. Okiyama, K.; Smith, D.H.; Gennarelli, T A.; Simon, R.P ; Ieach, M.; McIntosh, T.K J. Neurochem., 1995, 64, 802
118. Kinouchi, H., Imaizumi, S.; Toshimoto, T.; Masackchi, M. Stroke, 1990, 21, 13, 26.
119. Hille, B. Ionic Channels of Excitable Membranes, 2nd ed., Sinauer Associates, Inc.: Suderland, MA, 1992.
120. Catterall, W.A. Trends Pharmacol Sci., 1987, 8, 57
121. Roufos, L.; Hays, S.; Schwarz, R.D. J Med. Chem., 1996, 39, 1514.
122. Roufos, I.; Hays, S.; Dooley, D J ; Schwarz, R.D., Cambell, G.W.; Probert, A W., Jr. J. Med. Chem., 1994, 37, 268.
123. Gupta, S P ; Babu, M.S.; Anitha, P. Bioorg. Med Chem , Communicated.
124. Ritchie, J.M.; Greene, N.M. In The Pharmacological Basis of Therapeutics, 8th ed., Gillman, A.G ; Rall, T.W.; Nies, A S ; Taylor, P., Eds.; Pergamon Press: New York, 1990, p. 311.
125. Wang, G K J. Gen. Physiol., 1990, 96, 1105.
126. Ragsdale, D.S ; McPhee, J C.; Scheller, T ; Catterall, W A, Science, 1994, 265, 1724
127. Heymans, F.; Therizien, L L ; Godfroid, J J.; Besin, P. J. Med Chem , 1980, 23, 184
128. Hall, L H.; Kier, L.B Eur J. Med Chem., 1981, 16, 399.
129. Hall, L.H.; Kier, L.B. J. Pharm. Sci., 1983, 72, 1170.
130. Kier, L.B., Hall, L.H. Molecular Connectivity in Chemistry and Drug Research; Academic Press: New York, 1976.
131. Unger, S H In Quantitative Structure-Activity Relationships of Drugs, Topliss, J.G., Ed.; Academic Press: New York, 1983; p 177.
132. Unger, S H. In Drag Design; Ariens, E.J., Ed.; Academic Press, New York, 1980, Vol. 9, p. 47.
133. Grisham, C.M.; Barnett, R.E. Biochim Biophys Acta, 1973, 311, 417.
134. Unger, S.H.; Chiang, G.H. J. Med. Chem., 1981, 24, 262.
135. Davis, P.W.; Brody, T.M. Biochem. Pharmacol., 1966, 15, 703.
136. Eletr, S., Williams, M.A.; Walkins, T ; Keith, A.D. Biochim. Biophys Acta, 1974, 339, 190.
137. Johnson, C L.; Schwartz, A J. Pharmacol Exp. Ther., 1969, 167, 365
138. CAST investigators, N. Engl. J. Med., 1989, 321, 406.
139. Woosley, R.L. Clin. Pharmacol. Ther., 1990, 47, 553.
140. Echt, D.C.; Liebson, M D.; Mitchell, L.B.; et al. N. Engl. J. Med , 1991, 324, 781.
141. Sanguinetti, M.C.; Jurkiewicz, N K. J Gen. Physiol., 1990, 96, 195.
142. Barhanin, J ; Lesage, F , Guillemare, E.; Fink, M., Lazdunski, M., Romey, G. Nature, 1996, 384, 78
143. Sanguinetti, M C.; Curran, M.E , Zou, A.; Shen, J.; Spector, P.S ; Atkinson, D.L.; Keating, M.T. Nature, 1996, 384, 40.
144. Selnick, G.H., Liverton, N.J ; Baldwin, J J ; Butcher, J.W ; Claremon, D.A.; Elliott, J.M.; Freidinger, R.M.; King, S.A ; Libby, B E.; McIntyre, C.J.; Pribush, D A.; Remy, D.C.; Smith, G.R., Tebben, A.J.; Jurkiewicz, N K , Lynch, J.J.; Salata, J.J ; Sanguinetti, M.C.; Siegl, P.K.S ; Slaughter, D.E , Vyas, K J. Med Chem. 1997, 40, 3865